bioAffinity
  • Home
  • Publications
  • News
  • About
  • Contact
  • Investor Relations
Select Page
  • Home
  • Publications
  • News
  • About
  • Contact
  • Investor Relations

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Board Diversity
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Feb 25, 2025 9:58am EST

bioAffinity Technologies Announces Warrant Inducement for Aggregate Gross Proceeds of $1.4 Million

Jan 22, 2025 8:00am EST

bioAffinity Technologies Announces Acceptance of Patent Application for Early-Stage Lung Cancer Diagnostic

Jan 13, 2025 8:00am EST

bioAffinity Technologies Reports Positive Results from Texas Beta Launch of CyPath® Lung

Dec 17, 2024 8:00am EST

Join bioAffinity Technologies’ Exclusive Live Investor Webinar and Q&A Session on Thursday, December 19

Dec 12, 2024 8:00am EST

bioAffinity Technologies Set for Continued Expansion in 2025

Dec 05, 2024 8:00am EST

Veterans’ Research Foundation Spotlights CyPath® Lung’s Addition to the Federal Supply Schedule

Nov 14, 2024 8:00am EST

bioAffinity Technologies Reports $2.4 Million Revenue for Q3 2024

Nov 04, 2024 8:00am EST

bioAffinity Technologies Appoints New Chief Science Officer to Spearhead Product Development

Oct 30, 2024 8:00am EDT

bioAffinity Technologies Announces Award of Japanese Patent for CyPath® Lung

Oct 21, 2024 10:45am EDT

bioAffinity Technologies Announces Closing of $2.6 Million Registered Direct Offering & Concurrent Private Placement

  • arrow_back
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …13
  • arrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed


Phone

(210) 698-5334



Email

info@bioaffinitytech.com



LinkedIn

…/bioaffinitytechnologies



Twitter

@bioAffinity

Subscribe for News from bioAffinity Technologies

Subscribe
Copyright © 2025 bioAffinity Technologies, Inc.